Loading
Life sciences · Journal article
Immunobiology · September 25, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Obesity is increasingly recognized as a metabolic factor influencing immune regulation in sarcoidosis (SA). This study examined whether obesity alters immune-checkpoint expression on lymph-node–resident T cells in newly diagnosed, treatment-naïve SA patients. Sixty-three individuals underwent EBUS-TBNA with flow-cytometric analysis of lymph node (LN) aspirates and peripheral blood (PB), and were stratified into obese ( n = 18) and non-obese ( n = 45) groups. Obesity was associated with distinct LN-specific immunophenotypic changes, including markedly higher LAG-3 and CTLA-4 expression on CD4 + T cells and lower TIM-3 expression on CD8 + T cells. Obese patients also showed reduced high-fluorescent cell counts and lower lymphocyte fluorescence intensity, suggesting altered activation states. These differences were absent in PB, underscoring tissue-specific immune modulation. Pulmonary function was lower in obese patients but served mainly as a clinical correlate. Overall, obesity emerges as a relevant modifier of local T-cell regulation in SA, highlighting the value of LN-based immunophenotyping.